Olay PROx Eye Wand, page-30

I think we're just all conditioned to disappointment. For a long, LONG time.
Truth is, none of us knows what revenues to expect.
My only guidance is perfomance shares that kick in towards the end of next year for $20m revenue.
I suspect the recent share grab that was shouted down was only attempted because it's becoming clearer OBJ will not make that target in time.
Having said that, the fact directors originally expected they might make that target is good enough indication for me.